Yoshiko Umeyama
5PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 31, 2024
Phase 3 Study of Talazoparib Plus Enzalutamide Versus Placebo Plus Enzalutamide as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer: TALAPRO-2 Japanese Subgroup Analysis.Nobuaki Matsubara, Hideaki Miyake, Hiroji Uemura
|Aug 22, 2024
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer.Emi Noguchi, Takashi Yamanaka, Hirofumi Mukai
|May 06, 2021
Evaluation of the Association of Polymorphisms With Palbociclib-Induced Neutropenia: Pharmacogenetic Analysis of PALOMA-2/-3.Hiroji Iwata, Yoshiko Umeyama, Yuan Liu
|May 19, 2020
Palbociclib-letrozole as first-line treatment for advanced breast cancer: Updated results from a Japanese phase 2 study.Masato Takahashi, Norikazu Masuda, Reiki Nishimura
|Dec 29, 2019
Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101.Motohide Uemura, Yoshihiko Tomita, Hideaki Miyake
Pageof 1
Frequent Collaborators
1 joint publications
Shingo Hatakeyama
1 joint publications
Tomoyuki Kato
1 joint publications
Wataru Obara
1 joint publications
Norikazu Masuda
1 joint publications
Emi Noguchi
1 joint publications
Yen-Shen Lu
1 joint publications
Yoon Sim Yap
1 joint publications
Koji Matsumoto
1 joint publications
Yuki Kojima
1 joint publications
Tomomi Hata
